Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced that the U.S. Food and Drug Administration (FDA) has approved the premarket approval (PMA) application for the Allurion Gastric Balloon System, featuring the Allurion Smart Capsule.

The Allurion Smart Capsule is a state-of-the-art innovation covered by over 50 patents globally. The Smart Capsule is swallowed in a 15-minute office visit without the need for surgery, endoscopy, or anesthesia, filled with fluid once inside the stomach, and resides inside for approximately four months. During that time, it occupies space within the stomach, helping patients feel full and eat less. After approximately four months, the patented Release Valve opens, and it passes out of the body naturally. Another Smart Capsule can be swallowed two months after the passage of the first. Unlike medications that need to be administered daily or injected weekly, Allurion‘s approach results in approximately four months of treatment from a single administration.

• No comments yet. Be the first to comment!